MGNX - MacroGenics GAAP EPS of -$0.84 misses by $0.19 revenue of $9.1M misses by $5.76M
2024-05-09 16:29:30 ET
More on MacroGenics
- MacroGenics: Positive Safety Update Leads To Two Major Inflection Points In 2024
- MacroGenics, Inc. (MGNX) Q4 2023 Earnings Call Transcript
- MacroGenics: Evaluating Its Buy Status After A 200% Surge On Prostate Cancer Prospects
- MacroGenics Q1 2024 Earnings Preview
- MacroGenics gains after mid-stage data for antibody drug conjugate